2013
DOI: 10.1002/hep.26144
|View full text |Cite
|
Sign up to set email alerts
|

Bayesian prediction for liver fibrosis staging: Combined use of elastography and serum fibrosis markers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(15 citation statements)
references
References 7 publications
0
15
0
Order By: Relevance
“…Another advantage of the Bayesian method, which was not investigated in this study, is that we can combine more than one test, as we do mentally while arriving at a clinical decision . The Bayesian method enables addition of the results of secondary tests, thus increasing the posterior probability of the results (fibrosis staging in this case).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another advantage of the Bayesian method, which was not investigated in this study, is that we can combine more than one test, as we do mentally while arriving at a clinical decision . The Bayesian method enables addition of the results of secondary tests, thus increasing the posterior probability of the results (fibrosis staging in this case).…”
Section: Discussionmentioning
confidence: 99%
“…However, a cutoff method for staging always involves a compromise between sensitivity and specificity. The Bayesian method is another method to stage liver fibrosis besides the cutoff method . The Bayesian method calculates posttest (post‐MRE) probability of each stage of fibrosis, that is, the confidence of staging for each stage, yielding the most likely stage of fibrosis as well as the confidence level.…”
mentioning
confidence: 99%
“…MR Elastography technique has also been further validated for assessing diffused liver diseases (46,47). Along with technical improvements, integrated liver multi-parametric imaging will likely improve the sensitivity and specificity for early stage liver fibrosis characterization (48)(49)(50)(51)(52), or a combination of MR readout and serum fibrosis markers and the use of decision trees, such as Bayesian prediction, will allow high validity for a diagnostic approach (53,54).…”
Section: Bdl Is a Well Established Model For Liver Fibrosis Researchmentioning
confidence: 99%
“…Further, a prospective validation study that combines these methods would offer comfortable and low risk management of liver disease. 67,68 The current study had some limitations. First, we included no F0 case because of the minimal clinical requirement for performing a biopsy to evaluate fibrosis during early stages of liver disease.…”
Section: Discussionmentioning
confidence: 91%